On Target Laboratories, Inc. By efain on Wed, 09/16/2020 - 16:07 Read more about On Target Laboratories, Inc. Expanded Access Listings BRM421 Ophthalmic Solution in Patients With Limbal Stem Cell Deficiency Conditions Limbal Stem Cell Deficiency (LSCD) The goal of this program is to provide patients with Limbal Stem Cell Deficiency accessto the BRM421 eye drops.Participants will: - Use BRM421 two times a day for at least 12 weeks - Visit the clinic monthly for checkups and tests
Kazia Therapeutics Limited By efain on Thu, 09/03/2020 - 11:44 Read more about Kazia Therapeutics Limited
Expanded Access eRequest Physicians: Electronically request non-emergency use of medical products for your patients Read more about Expanded Access eRequest
COVID-19 Hub Learn more about COVID-19 clinical trials and expanded access opportunities Read more about COVID-19 Hub
BIO 300 Oral Suspension in Previously Hospitalized Long COVID Patients Read more about BIO 300 Oral Suspension in Previously Hospitalized Long COVID Patients
